Thymosin Beta-4 Boosts Blood Vessel Formation but Not Heart Pump Function After Heart Attack in Diabetic Rats
Thymosin beta-4 enhanced diabetic stem cell migration and blood vessel formation in vitro and increased capillary density after heart attack in diabetic rats, but did not improve overall heart pumping function.
Quick Facts
What This Study Found
Tβ4 at 10 ng/mL improved diabetic EPC migration, tubule formation, and angiogenic factor secretion in vitro, and increased capillary density in vivo, but only non-Tβ4-treated EPCs significantly improved left ventricular ejection fraction.
Key Numbers
10 ng/mL Tb4; MRI at 2, 4, 12 weeks; increased capillary density and c-Kit+ cells; no EF improvement
How They Did This
In vitro: Tβ4 treatment of diabetic EPCs measuring migration, tube formation, and growth factor secretion. In vivo: intramyocardial injection of Tβ4-treated vs untreated diabetic EPCs in obese diabetic rats after induced heart attack, measuring capillary density, progenitor cell recruitment, and cardiac function.
Why This Research Matters
Heart disease is the leading killer of diabetic patients, and their stem cells are impaired. Finding ways to restore diabetic stem cell function could improve outcomes after heart attacks in this vulnerable population.
The Bigger Picture
This study highlights the complexity of stem cell therapy in diabetes — improving individual cell behaviors (migration, vessel formation) does not automatically translate to improved organ-level function, suggesting additional factors affect cardiac recovery.
What This Study Doesn't Tell Us
Small animal model with unspecified group sizes. The paradox of improved vessel formation but not heart function is unexplained. Single Tβ4 dose tested. Short follow-up period likely.
Questions This Raises
- ?Why did Tβ4-treated EPCs increase vessel density but fail to improve ejection fraction?
- ?Would different Tβ4 doses or timing produce better cardiac function outcomes?
- ?Could combining Tβ4 with other cardiac repair peptides like BPC-157 improve results?
Trust & Context
- Key Stat:
- More vessels, same function Tβ4-treated cells increased capillary density but did not improve heart ejection fraction in diabetic rats
- Evidence Grade:
- Preliminary — small animal study with mixed results. The disconnect between vessel formation and cardiac function requires further investigation.
- Study Age:
- Published in 2020; thymosin beta-4 cardiac research continues with focus on optimizing dosing and delivery strategies.
- Original Title:
- Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4.
- Published In:
- Cells, 9(4) (2020)
- Authors:
- Poh, Kian Keong, Lee, Poay Sian Sabrina, Djohan, Andie Hartanto, Galupo, Mary Joyce, Songco, Geronica Gorospe, Yeo, Tiong Cheng, Tan, Huay Cheem, Richards, Arthur Mark, Ye, Lei
- Database ID:
- RPEP-05071
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is thymosin beta-4 and why test it on heart attack?
Thymosin beta-4 is a naturally occurring peptide critical for heart development in embryos. It promotes blood vessel formation and cell migration, making it a candidate for repairing heart tissue after a heart attack.
Why might more blood vessels not help heart function?
New blood vessels (capillaries) formed after a heart attack may not be fully functional — they might lack proper connections or flow regulation. Heart function depends on many factors beyond vessel density, including muscle viability and scar tissue formation.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05071APA
Poh, Kian Keong; Lee, Poay Sian Sabrina; Djohan, Andie Hartanto; Galupo, Mary Joyce; Songco, Geronica Gorospe; Yeo, Tiong Cheng; Tan, Huay Cheem; Richards, Arthur Mark; Ye, Lei. (2020). Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4.. Cells, 9(4). https://doi.org/10.3390/cells9040949
MLA
Poh, Kian Keong, et al. "Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4.." Cells, 2020. https://doi.org/10.3390/cells9040949
RethinkPeptides
RethinkPeptides Research Database. "Transplantation of Endothelial Progenitor Cells in Obese Dia..." RPEP-05071. Retrieved from https://rethinkpeptides.com/research/poh-2020-transplantation-of-endothelial-progenitor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.